REFERENCES
- Oya M, Akiyama Y, Yanagida T, Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. Surg Today. 1998;28:373.
- Sallah S, Wan JY, Nguyen NP, Disseminated intravascular coagulation in solid tumors: Clinical and pathologic study. Thromb Haemost. 2001;86:828.
- Dupuy E, Habib A, Lebret M, et al. Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1. J Thromb Haemost. 2003;1:1096–1102.
- Pirie-Shepherd SR. Regulation of angiogenesis by the hemostatic system. Front Biosci. 2003;8:d286–d293.
- Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans. 2002;30:173–177.
- Wojtukiewicz MZ, Sierko E, Klement P, et al. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001;3:371–384.
- Hall H, Baechi T, Hubbell JA. Molecular properties of fibrinbased matrices for promotion of angiogenesis in vitro. Microvasc Res. 2001;62:315–326.
- Blackwell K, Hurwitz H, Lieberman G, et al. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembriogenic antigen levels in patients with metastatic colorectal carcinoma. Cancer 2004;101:77–82.
- Oya M, Akiyama Y, Okuyama T, et al. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31: 388–394.
- Pezzella F, Pastorino U, Tagliabue E, et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol. 1997; 151(5):1417–23.
- Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans. 2002;30:173–177.
- Chiarug V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumor matrix. Mol Biotechnol. 2002;21:85–90.
- Wojtukiewicz MZ, Sierko E, Klement P, et al. The hemostatic system and angiogenesis in malignancy. Neoplasia 2001;3:371–384.
- Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen: the role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci. 2001;936:406–425.
- Wojtukiewicz MZ, Zimnoch L, Jaromin J, et al. Immunohistochemical demonstration of fibrin II in gastric cancer tissue. Pol J Pharmacol. 1996;48:229–232.
- Bell WR. The fibrinolytic system in neoplasia. Semin Thromb Hemost. 1996;22:459–478.
- Dvorak HF, Harvey VS, Estrella P, et al. Fibrin containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. Lab Invest. 1987;57:673– 686.
- Nicosia RF, Tchao R, Leighton J. Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res. 1983;43:2159–2166.
- Rickles FR, Levine MN, Dvorak HF, Abnormalities of hemostasis in malignancy. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 1131—1152.
- Roodhart JM, Langenberg MH, Witteveen E, et al. The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway. Curr Clin Pharmacol. 2008;3(2):132–143. Review.
- Okholm M, Iversen LH, Thorlacius-Ussing O, et al. Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma. Dis Colon Rectum. 1996;39(10):1102–1106.
- Gadducci A, Baicchi U, Marrai R, et al. Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses. Gynecol Oncol. 1996;60(2):197–202.
- Blackwell K, Hurwitz H, Liebérman G, et al. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer 2004;101(1):77–82.
- Gadducci A, Baicchi U, Marrai R, et al. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol. 1993;49(3):354–358.
- Gabazza EC, Taguchi O, Yamakami T, et al. Evaluating prethrombotic state in lung cancer using molecular markers. Chest 1993;103(1):196–200.